Next-generation muscle-directed gene therapy by in silico vector design

Adeno-associated viral vectors (AAV) are being developed for gene therapy of skeletal muscle, but it is a challenge to achieve robust gene expression. Here, the authors identify muscle-specific cisregulatory elements that lead to a substantial increase in micro-dystrophin and follistatin expression,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	S. Sarcar, W. Tulalamba, M. Y. Rincon, J. Tipanee, H. Q. Pham, H. Evens, D. Boon, E. Samara-Kuko, M. Keyaerts, M. Loperfido, E. Berardi, S. Jarmin, P. In’t Veld, G. Dickson, T. Lahoutte, M. Sampaolesi, P. De Bleser, T. VandenDriessche, M. K. Chuah
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2019
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/c5d6b54327424a9fb828402310c7a87f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c5d6b54327424a9fb828402310c7a87f
record_format	dspace
spelling	oai:doaj.org-article:c5d6b54327424a9fb828402310c7a87f2021-12-02T14:38:58ZNext-generation muscle-directed gene therapy by in silico vector design10.1038/s41467-018-08283-72041-1723https://doaj.org/article/c5d6b54327424a9fb828402310c7a87f2019-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-08283-7https://doaj.org/toc/2041-1723Adeno-associated viral vectors (AAV) are being developed for gene therapy of skeletal muscle, but it is a challenge to achieve robust gene expression. Here, the authors identify muscle-specific cisregulatory elements that lead to a substantial increase in micro-dystrophin and follistatin expression, resulting in a safe and sustainable rescue of the dystrophic phenotype in mouse models.S. SarcarW. TulalambaM. Y. RinconJ. TipaneeH. Q. PhamH. EvensD. BoonE. Samara-KukoM. KeyaertsM. LoperfidoE. BerardiS. JarminP. In’t VeldG. DicksonT. LahoutteM. SampaolesiP. De BleserT. VandenDriesscheM. K. ChuahNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-16 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q S. Sarcar W. Tulalamba M. Y. Rincon J. Tipanee H. Q. Pham H. Evens D. Boon E. Samara-Kuko M. Keyaerts M. Loperfido E. Berardi S. Jarmin P. In’t Veld G. Dickson T. Lahoutte M. Sampaolesi P. De Bleser T. VandenDriessche M. K. Chuah Next-generation muscle-directed gene therapy by in silico vector design
description	Adeno-associated viral vectors (AAV) are being developed for gene therapy of skeletal muscle, but it is a challenge to achieve robust gene expression. Here, the authors identify muscle-specific cisregulatory elements that lead to a substantial increase in micro-dystrophin and follistatin expression, resulting in a safe and sustainable rescue of the dystrophic phenotype in mouse models.
format	article
author	S. Sarcar W. Tulalamba M. Y. Rincon J. Tipanee H. Q. Pham H. Evens D. Boon E. Samara-Kuko M. Keyaerts M. Loperfido E. Berardi S. Jarmin P. In’t Veld G. Dickson T. Lahoutte M. Sampaolesi P. De Bleser T. VandenDriessche M. K. Chuah
author_facet	S. Sarcar W. Tulalamba M. Y. Rincon J. Tipanee H. Q. Pham H. Evens D. Boon E. Samara-Kuko M. Keyaerts M. Loperfido E. Berardi S. Jarmin P. In’t Veld G. Dickson T. Lahoutte M. Sampaolesi P. De Bleser T. VandenDriessche M. K. Chuah
author_sort	S. Sarcar
title	Next-generation muscle-directed gene therapy by in silico vector design
title_short	Next-generation muscle-directed gene therapy by in silico vector design
title_full	Next-generation muscle-directed gene therapy by in silico vector design
title_fullStr	Next-generation muscle-directed gene therapy by in silico vector design
title_full_unstemmed	Next-generation muscle-directed gene therapy by in silico vector design
title_sort	next-generation muscle-directed gene therapy by in silico vector design
publisher	Nature Portfolio
publishDate	2019
url	https://doaj.org/article/c5d6b54327424a9fb828402310c7a87f
work_keys_str_mv	AT ssarcar nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT wtulalamba nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT myrincon nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT jtipanee nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT hqpham nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT hevens nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT dboon nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT esamarakuko nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT mkeyaerts nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT mloperfido nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT eberardi nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT sjarmin nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT pintveld nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT gdickson nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT tlahoutte nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT msampaolesi nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT pdebleser nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT tvandendriessche nextgenerationmuscledirectedgenetherapybyinsilicovectordesign AT mkchuah nextgenerationmuscledirectedgenetherapybyinsilicovectordesign
_version_	1718390795982077952

Next-generation muscle-directed gene therapy by in silico vector design

Ejemplares similares